You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 277 No. 21, June 4, 1997 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Coronary Thrombolysis for the Elderly

Is Clinical Practice Really Lagging Behind Evidence of Benefit?

Jerry H. Gurwitz, MD; Robert J. Goldberg, PhD

JAMA. 1997;277(21):1723-1724.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Given the low survival experience of older persons following acute myocardial infarction,1 claims that thrombolytic therapy is underused in this patient population are particularly disconcerting. Regional, national, and multinational populationbased studies of age-related patterns of thrombolytic use have provided support for these assertions.2,3 It is unclear, however, to what extent these patterns of care reflect age bias in the use of an effective therapy vs the appropriately cautious use of a treatment that carries inherent risks and for which only a limited number of elderly patients with acute myocardial infarction are eligible. In this issue of The JOURNAL, Krumholz et al4 provide evidence suggesting that the answer to this question probably lies somewhere between these 2 extremes.

See also p 1683.

In their study, the authors carefully analyzed data from the medical records of 3093 Medicare beneficiaries, aged 65 years and older, admitted to all acute care . . . [Full Text PDF of this Article]


Author Affiliations

From the Meyers Primary Care Institute, University of Massachusetts Medical Center and the Fallon Healthcare System, and the Department of Medicine, University of Massachusetts Medical School, Worcester, Mass.


Footnotes

Dr Gurwitz has served as a consultant for Genentech, South San Francisco, Calif, for a 1-day period to assist in database analysis. Compensation for his services was paid to the Meyers Primary Care Institute.

Reprints: Jerry H. Gurwitz, MD, The Meyers Primary Care Institute, University of Massachusetts Medical Center and the Fallon Healthcare System, 100 Central St, Worcester, MA 01608.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.